283 related articles for article (PubMed ID: 38626250)
21. Hydroxychloroquine in COVID-19: Potential Mechanism of Action Against SARS-CoV-2.
Satarker S; Ahuja T; Banerjee M; E VB; Dogra S; Agarwal T; Nampoothiri M
Curr Pharmacol Rep; 2020; 6(5):203-211. PubMed ID: 32864299
[TBL] [Abstract][Full Text] [Related]
22. Chloroquine and Hydroxychloroquine: Efficacy in the Treatment of the COVID-19.
Ho TC; Wang YH; Chen YL; Tsai WC; Lee CH; Chuang KP; Chen YA; Yuan CH; Ho SY; Yang MH; Tyan YC
Pathogens; 2021 Feb; 10(2):. PubMed ID: 33671315
[TBL] [Abstract][Full Text] [Related]
23. Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases.
Rainsford KD; Parke AL; Clifford-Rashotte M; Kean WF
Inflammopharmacology; 2015 Oct; 23(5):231-69. PubMed ID: 26246395
[TBL] [Abstract][Full Text] [Related]
24. Impact of Hydroxychloroquine/Chloroquine in COVID-19 Therapy: Two Sides of the Coin.
Fatima U; Rizvi SSA; Fatima S; Hassan MI
J Interferon Cytokine Res; 2020 Oct; 40(10):469-471. PubMed ID: 32881593
[TBL] [Abstract][Full Text] [Related]
25. Chloroquine and COVID-19-A systems biology model uncovers the drug's detrimental effect on autophagy and explains its failure.
Kapuy O; Korcsmáros T
PLoS One; 2022; 17(4):e0266337. PubMed ID: 35390060
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic use of chloroquine and hydroxychloroquine in COVID-19 and other viral infections: A narrative review.
Hashem AM; Alghamdi BS; Algaissi AA; Alshehri FS; Bukhari A; Alfaleh MA; Memish ZA
Travel Med Infect Dis; 2020; 35():101735. PubMed ID: 32387694
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of hydroxychloroquine/chloroquine against SARS-CoV-2 infection: A systematic review and meta-analysis.
Kumar J; Jain S; Meena J; Yadav A
J Infect Chemother; 2021 Jun; 27(6):882-889. PubMed ID: 33678548
[TBL] [Abstract][Full Text] [Related]
28. Chloroquine and hydroxychloroquine as a repurposed agent against COVID-19: a narrative review.
Acharya Y; Sayed A
Ther Adv Infect Dis; 2020; 7():2049936120947517. PubMed ID: 32821381
[TBL] [Abstract][Full Text] [Related]
29. Effect of chloroquine and hydroxychloroquine on COVID-19 virological outcomes: An updated meta-analysis.
Das RR; Behera B; Mishra B; Naik SS
Indian J Med Microbiol; 2020; 38(3 & 4):265-272. PubMed ID: 33154234
[TBL] [Abstract][Full Text] [Related]
30. Hydroxychloroquine as an aerosol might markedly reduce and even prevent severe clinical symptoms after SARS-CoV-2 infection.
Klimke A; Hefner G; Will B; Voss U
Med Hypotheses; 2020 Sep; 142():109783. PubMed ID: 32402766
[TBL] [Abstract][Full Text] [Related]
31. Characterization of the Modulatory Effect of Hydroxychloroquine on ACE2 Activity: New Insights in relation to COVID-19.
Tichauer JE; Soto D; Andresen M
Biomed Res Int; 2021; 2021():6614000. PubMed ID: 34337036
[TBL] [Abstract][Full Text] [Related]
32. Chloroquine and Hydroxychloroquine for the Prevention and Treatment of COVID-19: A Fiction, Hope or Hype? An Updated Review.
Saghir SAM; AlGabri NA; Alagawany MM; Attia YA; Alyileili SR; Elnesr SS; Shafi ME; Al-Shargi OYA; Al-Balagi N; Alwajeeh AS; Alsalahi OSA; Patra AK; Khafaga AF; Negida A; Noreldin A; Al-Amarat W; Almaiman AA; El-Tarabily KA; Abd El-Hack ME
Ther Clin Risk Manag; 2021; 17():371-387. PubMed ID: 33953559
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of chloroquine and hydroxychloroquine for treatment of COVID-19 patients-a systematic review and meta-analysis of randomized controlled trials.
Eze P; Mezue KN; Nduka CU; Obianyo I; Egbuche O
Am J Cardiovasc Dis; 2021; 11(1):93-107. PubMed ID: 33815925
[TBL] [Abstract][Full Text] [Related]
34. Hydroxychloroquine/Chloroquine as Therapeutics for COVID-19: Truth under the Mystery.
Chen Y; Li MX; Lu GD; Shen HM; Zhou J
Int J Biol Sci; 2021; 17(6):1538-1546. PubMed ID: 33907517
[TBL] [Abstract][Full Text] [Related]
35. Review of Hydroxychloroquine Cardiotoxicity: Lessons From the COVID-19 Pandemic.
Gagnon LR; Sadasivan C; Yogasundaram H; Oudit GY
Curr Heart Fail Rep; 2022 Dec; 19(6):458-466. PubMed ID: 36167917
[TBL] [Abstract][Full Text] [Related]
36. Chloroquine and hydroxychloroquine ototoxicity; potential implications for SARS-CoV-2 treatment. A brief review of the literature.
De Luca P; Scarpa A; De Bonis E; Cavaliere M; Viola P; Gioacchini FM; Ralli M; Ettore C; Claudia C
Am J Otolaryngol; 2021; 42(5):102640. PubMed ID: 33780902
[TBL] [Abstract][Full Text] [Related]
37. Chloroquine and Hydroxychloroquine for the Prevention or Treatment of COVID-19 in Africa: Caution for Inappropriate Off-label Use in Healthcare Settings.
Abena PM; Decloedt EH; Bottieau E; Suleman F; Adejumo P; Sam-Agudu NA; Muyembe TamFum JJ; Seydi M; Eholie SP; Mills EJ; Kallay O; Zumla A; Nachega JB
Am J Trop Med Hyg; 2020 Jun; 102(6):1184-1188. PubMed ID: 32323646
[TBL] [Abstract][Full Text] [Related]
38. Chloroquine and Hydroxychloroquine for the Treatment of COVID-19: a Systematic Review and Meta-analysis.
Elavarasi A; Prasad M; Seth T; Sahoo RK; Madan K; Nischal N; Soneja M; Sharma A; Maulik SK; Shalimar ; Garg P
J Gen Intern Med; 2020 Nov; 35(11):3308-3314. PubMed ID: 32885373
[TBL] [Abstract][Full Text] [Related]
39. Cardiovascular adverse events associated with hydroxychloroquine and chloroquine: A comprehensive pharmacovigilance analysis of pre-COVID-19 reports.
Goldman A; Bomze D; Dankner R; Hod H; Meirson T; Boursi B; Maor E
Br J Clin Pharmacol; 2021 Mar; 87(3):1432-1442. PubMed ID: 32964535
[TBL] [Abstract][Full Text] [Related]
40. Challenges and cares to promote rational use of chloroquine and hydroxychloroquine in the management of coronavirus disease 2019 (COVID-19) pandemic: a timely review.
Pereira BB
J Toxicol Environ Health B Crit Rev; 2020 May; 23(4):177-181. PubMed ID: 32281481
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
